Terrie Starling is a Senior Therapeutic Specialist at Gilead Sciences, where they promote Trodelvy in various oncology markets. Previously, Terrie held positions at numerous notable companies, including AstraZeneca and Genentech, achieving recognition such as the ONE Oncology Award and multiple regional and national accolades. They also founded the Northern New England Bladder Cancer Advocacy Chapter, demonstrating a commitment to advocacy and education in cancer care. Terrie earned a Bachelor of Arts in English and French from Mount Allison University and an Applied Information Technology Diploma from the ITI.
This person is not in the org chart
This person is not in any teams
This person is not in any offices